Annual Secretarial Compliance Report for the financial year ended March 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zenotech Laboratories has filed its Annual Secretarial Compliance Report for FY25, certifying that it has complied with SEBI regulations on secretarial standards, insider trading, related party transactions, board evaluations, and timely event disclosures. No SEBI or stock exchange actions were taken against the company during the year. However, the Practicing Company Secretary flagged a continuing non-compliance: the company has not been able to prepare consolidated financial statements or upload audited financials of its overseas subsidiaries on its website, as required under Regulation 46, because the books and records of its overseas subsidiaries are missing or unavailable. Investments in these subsidiaries have been written off, and management is working on closing them and filing the necessary documents with the RBI. The same observation has been carried forward from FY20, FY21, FY22, FY23 and FY24 reports, with steps including approval of voluntary winding up of Zenotech Laboratories Nigeria Limited and appointment of consultants for due diligence.
Mostly a routine compliance filing with no new penalties or regulatory action. The key concern for shareholders is the unresolved subsidiary issue spanning multiple years, which has prevented the company from publishing consolidated financials — investors should watch for updates on the RBI closure process and any eventual resumption of consolidated reporting.